|
|
|
|
Vol. 53, Issue 6, 1016-1026, June 1998
Department of Biochemistry and Molecular Biology (K.C.F., M.W.L.,
R.A.P.), University of Louisville School of Medicine, Louisville,
Kentucky 40292, and
Merck Research Laboratory (T.H.R.), West Point,
Pennsylvania 19486
Glucocorticoids (GCs) repress both basal and polyaromatic
hydrocarbon-induced expression of the glutathione
S-transferase Ya1 gene
(gstA2) in isolated rat hepatocytes and rat liver
in vivo. Transient transfection experiments with HepG2
cells were used to identify GC-responsive elements (GREs). With
cotransfected GC receptor, chloramphenicol acetyltransferase (CAT)
constructs containing a palindromic GRE (pGRE) and three GRE
hexanucleotide half-sites between
1.6 and
1.1 kb of the 5'-flanking
region of gstA2 were repressed >50% by GC when induced
with polyaromatic hydrocarbon. This pGRE, if either mutated or deleted,
significantly reduces GC responsiveness of the gene to 20-30%; no
effect of GC was observed with CAT constructs containing
1.15 kb of
the 5'-flanking region. The dexamethasone concentration dependence of
the repression was consistent with involvement of the GC receptor and
was antagonized by RU38486. Electrophoretic mobility shift assays
demonstrated that pGRE formed a specific DNA/protein complex, which was
prevented by the addition of excess unlabeled or mouse mammary tumor
virus GRE but not by unrelated or mutated gstA2 GRE
double-stranded oligonucleotides. This complex was supershifted by
incubation of nuclear extracts containing GC receptor with anti-GC
receptor globulins. Constructs containing multiple copies of pGRE
sequence were either nonresponsive or positively responsive (three
copies) to GC. Luciferase constructs containing
1.62 to
1.03 kb of
the 5'-flanking region also were regulated positively by GC. Chimeric
GC-peroxisome proliferator activated receptor activated the constructs
that were positively responsive to GC but did not mediate the negative
effect in constructs containing 1.6 kb of 5'-flanking region. We
conclude that pGRE and half-site GREs of gstA2
participate in regulation of this gene; however, a second unidentified
responsive element must exist between
1.03 and
0.164 kb, resulting
in repression of gstA2 expression.
This article has been cited by other articles:
![]() |
K. C. Falkner, J. K. Ritter, and R. A. Prough Regulation of the Rat UGT1A6 by Glucocorticoids Involves a Cryptic Glucocorticoid Response Element Drug Metab. Dispos., February 1, 2008; 36(2): 409 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Ki, I. J. Cho, D. W. Choi, and S. G. Kim Glucocorticoid Receptor (GR)-Associated SMRT Binding to C/EBP{beta} TAD and Nrf2 Neh4/5: Role of SMRT Recruited to GR in GSTA2 Gene Repression Mol. Cell. Biol., May 15, 2005; 25(10): 4150 - 4165. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Necela and J. A. Cidlowski Mechanisms of Glucocorticoid Receptor Action in Noninflammatory and Inflammatory Cells Proceedings of the ATS, November 1, 2004; 1(3): 239 - 246. [Full Text] [PDF] |
||||
![]() |
S. L. Ripp, K. C. Falkner, M. L. Pendleton, V. Tamasi, and R. A. Prough Regulation of CYP2C11 by Dehydroepiandrosterone and Peroxisome Proliferators: Identification of the Negative Regulatory Region of the Gene Mol. Pharmacol., July 1, 2003; 64(1): 113 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Ripp, J. L. Fitzpatrick, J. M. Peters, and R. A. Prough Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor Drug Metab. Dispos., May 1, 2002; 30(5): 570 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Falkner, J. A. Pinaire, G.-H. Xiao, T. E. Geoghegan, and R. A. Prough Regulation of the Rat Glutathione S-Transferase A2 Gene by Glucocorticoids: Involvement of Both the Glucocorticoid and Pregnane X Receptors Mol. Pharmacol., September 1, 2001; 60(3): 611 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine, et al. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors Drug Metab. Dispos., April 13, 2001; 29(5): 623 - 633. [Abstract] [Full Text] |
||||